Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.
Novel treatment disrupts tumor immunosuppression in pancreatic cancer
- Post author:admin
- Post published:September 26, 2025
- Post category:uncategorized